GlassScriptPhysician profile
Stephen D Milan
NPI 1295029635
$129,848.81
in general payments reported to CMS, 2019-2025
38 companies · $43K in 2025
The $43K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $467 · 2021: $385 · 2022: $431 · 2023: $29K · 2024: $56K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $102K · Food and Beverage: $13K · Education: $9,028 · Travel and Lodging: $3,968 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $102,475.00 |
| Food and Beverage | $12,728.40 |
| Education | $9,027.62 |
| Travel and Lodging | $3,968.45 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $82,180.36 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $20,835.87 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Intuitive Surgical, INC. | $20,346.89 | 2023-2025 | Ion, Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,050.89 | 2019-2025 | Ofev, Stiolto Respimat |
| Medical Device Business Services, INC. | $898.12 | 2023 | Na |
| Olympus Corporation of The Americas | $637.58 | 2025 | Spiration Valve System |
| Galvanize Therapeutics, INC | $561.12 | 2025 | Aliya System |
| Genzyme Corporation | $295.22 | 2023-2025 | |
| Olympus America INC. | $288.01 | 2025 | Spiration Valve System, Single-Use Flexible Video Bronchoscope |
| Takeda Pharmaceuticals U.S.A., INC. | $286.11 | 2022-2025 | Glassia |
| Insmed, INC. | $282.68 | 2023-2025 | Arikayce |
| Philips North America LLC | $198.29 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Regeneron Healthcare Solutions, INC. | $197.15 | 2023-2025 | Dupixent |
| Atricure, INC. | $165.41 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Inogen, INC. | $164.94 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $144.24 | 2025 | Ohtuvayre |
| Baxter Healthcare | $114.97 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Monarch Airway Clearance System |
| Pentax of America, INC. | $113.60 | 2021 | |
| Amgen INC. | $107.88 | 2022-2024 | Tezspire |
| Merck Sharp & Dohme LLC | $100.43 | 2020-2025 | Zerbaxa, Recarbrio |
| Ambu INC. | $98.37 | 2025 | |
| Janssen Pharmaceuticals, INC | $94.17 | 2019-2024 | Xarelto |
| United Therapeutics Corporation | $92.16 | 2021-2024 | Tyvaso |
| Grifols USA, LLC | $62.33 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $61.11 | 2024 | Uptravi, Opsumit |
| Fisher & Paykel Healthcare INC | $56.21 | 2024 | Fisher & Paykel Healthcare |
| Pulmonx Corporation | $53.05 | 2022-2024 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Mylan Specialty L.P. | $52.41 | 2024 | Yupelri |
| Viatris Specialty LLC | $43.64 | 2025 | Yupelri |
| Lilly USA, LLC | $43.48 | 2025 | Zepbound, Mounjaro |
| Csl Behring | $38.77 | 2023 | Kcentra |
| Tactile Systems Technology INC | $33.53 | 2025 | Nimbl, Flexitouch Plus |
| Bayer Healthcare Pharmaceuticals INC. | $32.53 | 2019-2020 | |
| Inspire Medical Systems, INC. | $26.98 | 2024 | Inspire |
| Abbvie INC. | $25.56 | 2022 | |
| Caris Mpi, INC. | $24.59 | 2025 | Mi Cancer Seek |
| Boston Scientific Corporation | $22.92 | 2024 | Epic Biliary |
| La Jolla Pharmaceutical Company | $17.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Milan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.